All News

In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.

Your daily dose of clinical news you may have missed.

Infants with neonatal opioid withdrawal syndrome cared for using a novel functional approach were discharged nearly 7 days sooner than those treated with usual care.

One in 5 US adults without access to transportation skipped medical care last year, with racial/ethnic minorities at greatest risk, study finds.

A combination of outreach measures tailored to the needs of rural Midwest women increased recommended screenings by as much as 6-fold.

Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.

Your daily dose of clinical news you may have missed.

The US health care provider community continues to do its collective best to cope with the protean condition that is long COVID, according to recent poll findings.

Persons with long COVID showed compensatory neural activity in certain brain areas while performing memory tasks as long as 6 months after infection resolved.

Vowst is the first and only FDA-approved orally administered microbiota-based therapeutic for the prevention of recurrent C. diff infection in adults.

"Disconnect" on anticoagulation between MDs and patients; NASH resolves after bariatric surgery; antiobesity medications are not weight-loss drugs; plus 2 more updates of note.

Dubbed the "twincretin," the GLP-1/GIP RA met weight and HgbA1c reduction endpoints, with nearly half of tirzepatide-treated patients achieving weight loss of at least 15%.

The AHRQ, Mayo Clinic, AMA, and National Academy of Medicine each recommend actions steps for all organizational levels to help build more supportive environments.

For persons diagnosed with obesity, a prescription antiobesity medication is just one part of optimal care that includes significant lifestyle change as well, says Caroline Apovian, MD.

In gummy products with melatonin, the actual amount ranged from 74% to 347% of the labeled quantity, according to a new analysis.

Your daily dose of clinical news you may have missed.

Apovian: GLP-1 receptor agonists are the first antiobesity medications to simulate human physiology, which is why they sustain weight loss and are meant for long-term use.

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.